Assessment to barriers of medication adherence among patients with Type 2 Diabetes Mellitus

Abstract

Medication adherence among diabetes mellitus (DM) patients in Indonesia was predominantly low or nonadherent. Poor adherence raises the risk of developing diabetes-related complications. Specific barriers contribute to the lack of adherence DM patients. The study aimed to identify barriers to medication adherence among DM patients in a primary healthcare center in Indonesia. The cross-sectional study was conducted in 27 primary healthcare centers in Banjarmasin, Indonesia. Patients with DM type 2 were recruited using a purposive sampling technique between February and March 2023. The Diabetes Medication Adherence Barriers Questionnaire (DMAB-Q) was used to assess barriers to medication adherence. A total of 455 patients with type 2 DM participated in this study. The results of the study found that there were various barriers to medication adherence. In terms of medication-related factors, symptoms that do not immediately improve (65,1%), side effects (55,4%), and the complexity of the medication regimen (58,9%) were reported. Regarding patient-related factors, lack of understanding of treatment goals (65,1%), negative perception of medication (53,0%), take medicine only when ordered by the pharmacist (32,5%), forgetting to take medication (28,4%), feeling bored, and feeling obligated to take medication every day (43,3%) were identified. As for pharmacistrelated factors, the inability of patients to consult pharmacists promptly when encountering issues with their diabetes medication was prevalent (76,9%). Based on this study, it can be concluded that patient-related factors are the most dominant barriers to medication adherence among patients with diabetes mellitus.

Keywords

• Type 2 diabetes mellitus
• adherence barrier
• non-adherence
• compliance
• primary care

References

1. [1] ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Gaglia JL, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA. .2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46:19-40. https://doi.org/10.2337/dc23-S002
2. [2] Ojo OA, Ibrahim HS, Rotimi DE, Ogunlakin AD, Ojo AB. Diabetes mellitus: From molecular mechanism to pathophysiology and pharmacology. Med Nov Technol Devices. 2023;19:247-255. https://doi.org/10.1016/j.medntd.2023.100247
3. [3] Alshahrani JA, Alshahrani AS, Alshahrani AM, Alshalaan AM, Alhumam MN, Alshahrani NZt. The Impact of Diabetes Mellitus Duration and Complications on Health-Related Quality of Life Among Type 2 Diabetic Patients in Khamis Mushit City, Saudi Arabia. Cureus. 2023;15(8):e44216. https://doi.org/10.7759/cureus.44216
4. [4] Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 2022;18:525-539. https://doi.org/10.1038/s41574-022-00690-7
5. [5] Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6:1246-1258. https://doi.org/10.4239/wjd.v6.i13.1246
6. [6] Animaw W, Seyoum Y. Increasing prevalence of diabetes mellitus in a developing country and its related factors. PLoS One. 2017;12(11):e0187670.https://doi.org/10.1371/journal.pone.0187670
7. [7] Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes - Global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10:107-111. https://doi.org/10.2991/jegh.k.191028.001
8. [8] GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet.

9. 2023;402(10397):203-234. doi:10.1016/S0140-6736(23)01301-6. Erratum in: Lancet. 2023;402(10408):1132. doi: 10.1016/S0140-6736(23)02044-5. Erratum in: Lancet. 2025;405(10474):202. https://doi.org/10.1016/S0140-6736(23)01301-6
10. [9] Wahidin M, Achadi A, Besral B, Kosen S, Nadjib M, Nurwahyuni A, Ronoatmodjo S, Rahajeng E, Pane M, Kusuma D. Projection of diabetes morbidity and mortality till 2045 in Indonesia based on risk factors and NCD prevention and control programs. Sci Rep. 2024;14:5424-5441. https://doi.org/10.1038/s41598-024-54563-2
11. [10] Soeatmadji DW, Rosandi R, Saraswati MR, Sibarani RP, Tarigan WO. Clinicodemographic Profile and Outcomes of Type 2 Diabetes Mellitus in the Indonesian Cohort of DISCOVER: A 3-Year Prospective Cohort Study. J ASEAN Fed Endocr Soc. 2023;38:68-74. https://doi.org/10.15605/jafes.038.01.10
12. [11] Sankar V, Justin A, Matin PH, Pradeep S, Charan Kumar NS. Medication adherence and clinical outcomes in type 2 diabetes mellitus patients with depression: a prospective interventional study. J Res Pharm. 2018;22:269-276. https://doi.org/10.12991/jrp.2018.102
13. [12] Presley B, Groot W, Pavlova M. Pharmacy-led interventions to improve medication adherence among adults with diabetes: A systematic review and meta-analysis. Res Social Adm Pharm. 2019;15:1057-1067. https://doi.org/10.1016/j.sapharm.2018.09.021
14. [13] Yilmaz Z, Bulut K. Necessity and impact of patient education driven by pharmacist on the knowledge level of diabetic patients. J Res Pharm. 2023;27:1911-1923. https://doi.org/10.29228/jrp.473
15. [14] Liu H, Yao Z, Shi S, Zheng F, Li X, Zhong Z. The Mediating effect of self-efficacy on the relationship between medication literacy and medication adherence among patients with Type 2 Diabetes. Patient Prefer Adherence. 2023;17:1657-1670. https://doi.org/10.2147/PPA.S413385
16. [15] Alsaidan AA, Alotaibi SF, Thirunavukkarasu A, BF AL, Alharbi RH, Arnous MM, Alsaidan OA, Alduraywish AS, Alwushayh YA. Medication adherence and its associated factors among patients with Type 2 Diabetes Mellitus attending primary health centers of eastern province, Saudi Arabia. Medicina (Kaunas). 2023;59(5):989. https://doi.org/10.3390/medicina59050989
17. [16] Panahi S, Rathi N, Hurley J, Sundrud J, Lucero M, Kamimura A. Patient Adherence to Health Care Provider Recommendations and Medication among Free Clinic Patients. J Patient Exp. 2022;9:23743735221077523. https://doi.org/10.1177/23743735221077523
18. [17] Bombard Y, Baker GR, Orlando E, Fancott C, Bhatia P, Casalino S, Onate K, Denis JL, Pomey MP. Engaging patients to improve quality of care: a systematic review. Implement Sci. 2018 ;13(1):98. https://doi.org/10.1186/s13012-018-0784-z
19. [18] Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32:725-737. https://doi.org/10.1111/dme.12651
20. [19] Khunti K, Seidu S, Kunutsor S, Davies M. Association between adherence to pharmacotherapy and outcomes in Type 2 Diabetes: A Meta-analysis. Diabetes Care. 2017;40:1588-1596. https://doi.org/10.2337/dc16-1925
21. [20] Piragine E, Petri D, Martelli A, Calderone V, Lucenteforte E. Adherence to oral antidiabetic drugs in patients with Type 2 Diabetes: Systematic review and meta-analysis. J Clin Med. 2023;12:1981-2004. https://doi.org/10.3390/jcm12051981
22. [21] Kvarnstrom K, Westerholm A, Airaksinen M, Liira H. Factors contributing to medication adherence in patients with a chronic condition: A scoping review of qualitative research. Pharmaceutics. 2021;13:1100-1141. https://doi.org/10.3390/pharmaceutics13071100
23. [22] Kardas P. From non-adherence to adherence: Can innovative solutions resolve a longstanding problem? Eur J Intern Med. 2024;119:6-12. https://doi.org/10.1016/j.ejim.2023.10.012
24. [23] Pertiwi MV, Alfian R, Nita Y, Athiyah U. Medication adherence of diabetes mellitus patients in Indonesia: A systematic review. Pharm Edu. 2022;2:188-193. https://doi.org/10.46542/pe.2022.222.188193
25. [24] Kao CC, Hsieh HM, Lee DY, Hsieh KP, Sheu SJ. Importance of medication adherence in treatment needed diabetic retinopathy. Sci Rep. 2021;11:1910-1918. https://doi.org/10.1038/s41598-021-98488-6
26. [25] Faisal K, Tusiimire J, Yadesa TM. Prevalence and factors associated with non-adherence to antidiabetic medication among patients at Mbarara Regional Referral Hospital, Mbarara, Uganda. Patient Prefer Adherence. 2022;16:479-491. https://doi.org/10.2147/PPA.S343736
27. [26] Araya EM, Gebrezgabiher HA, Tekulu GH, Alema NM, Getnet D, Gebru HT, Adamu BA. Medication non-adherence and associated factors among diabetic patients visiting general hospitals in the eastern zone of Tigrai, Northern Ethiopia. Patient Prefer Adherence. 2020;14:2071-2083. https://doi.org/10.2147/PPA.S278148
28. [27] Rezaei M, Valiee S, Tahan M, Ebtekar F, Ghanei Gheshlagh R. Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study. Diabetes Metab Syndr Obes. 2019;12:589-599. https://doi.org/10.2147/DMSO.S197159
29. [28] Nelson LA, Wallston KA, Kripalani S, LeStourgeon LM, Williamson SE, Mayberry LS. Assessing barriers to diabetes medication adherence using the Information-Motivation-Behavioral skills model. Diabetes Res Clin Pract. 2018;142:374-384. https://doi.org/10.1016/j.diabres.2018.05.046
30. [29] Huang YM, Shiyanbola OO. Investigation of barriers and facilitators to medication adherence in patients with Type 2 Diabetes across different health literacy levels: An explanatory sequential mixed methods study. Front Pharmacol. 2021;12:745749. https://doi.org/10.3389/fphar.2021.745749
31. [30] Muller S, Kohlmann T, Wilke T. Validation of the adherence barriers questionnaire - an instrument for identifying potential risk factors associated with medication-related non-adherence. BMC Health Serv Res. 2015;15:153-165. https://doi.org/10.1186/s12913-015-0809-0
32. [31] Hatah E, Rahim N, Makmor-Bakry M, Mohamed Shah N, Mohamad N, Ahmad M, Haron NH, Sze Hwe C, Tan Meng Wah A, Hassan F, Shaik Rahmat S, Robert SA, Abdullah N. Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients. PLoS One. 2020;15(11):e0241909. https://doi.org/10.1371/journal.pone.0241909
33. [32] Atinga RA, Yarney L, Gavu NM. Factors influencing long-term medication non-adherence among diabetes and hypertensive patients in Ghana: A qualitative investigation. PLoS One. 2018;13(3):e0193995.https://doi.org/10.1371/journal.pone.0193995
34. [33] Rosendal M, Carlsen AH, Rask MT, Moth G. Symptoms as the main problem in primary care: A cross-sectional study of frequency and characteristics. Scand J Prim Health Care. 2015;33:91-99. https://doi.org/10.3109/02813432.2015.1030166
35. [34] Telo GH, de Souza MS, Andrade TS, Schaan BD. Comparison between adherence assessments and blood glucose monitoring measures to predict glycemic control in adults with type 1 diabetes: a cross-sectional study. Diabetol Metab Syndr. 2016;8:54-60. https://doi.org/10.1186/s13098-016-0162-4
36. [35] Sendekie AK, Netere AK, Kasahun AE, Belachew EA. Medication adherence and its impact on glycemic control in type 2 diabetes mellitus patients with comorbidity: A multicenter cross-sectional study in Northwest Ethiopia. PLoS One. 2022;17(9):e0274971. https://doi.org/10.1371/journal.pone.0274971
37. [36] Suprapti B, Izzah Z, Anjani AG, Andarsari MR, Nilamsari WP, Nugroho CW. Prevalence of medication adherence and glycemic control among patients with type 2 diabetes and influencing factors: A cross-sectional study. Glob Epidemiol. 2023;5:100113. https://doi.org/10.1016/j.gloepi.2023.100113
38. [37] Lin LK, Sun Y, Heng BH, Chew DEK, Chong PN. Medication adherence and glycemic control among newly diagnosed diabetes patients. BMJ Open Diabetes Res Care. 2017 ;5(1):e000429. https://doi.org/10.1136/bmjdrc-2017-000429
39. [38] Alodhaib G, Alhusaynan I, Mirza A, Almogbel Y. Qualitative exploration of barriers to medication adherence among patients with uncontrolled Diabetes in Saudi Arabia. Pharmacy (Basel). 2021;9(1):16. https://doi.org/10.3390/pharmacy9010016
40. [39] Jaam M, Hadi MA, Kheir N, Mohamed Ibrahim MI, Diab MI, Al-Abdulla SA, Awaisu A. A qualitative exploration of barriers to medication adherence among patients with uncontrolled diabetes in Qatar: integrating perspectives of patients and health care providers. Patient Prefer Adherence. 2018;12:2205-2216. http://dx.doi.org/10.2147/PPA.S174652
41. [40] Jaam M, Mohamed Ibrahim MI, Kheir N, Hadi MA, Diab MI, Awaisu A. Assessing prevalence of and barriers to medication adherence in patients with uncontrolled diabetes attending primary healthcare clinics in Qatar. Prim Care Diabetes. 2018;12:116-125. https://doi.org/10.1016/j.pcd.2017.11.001
42. [41] Krzeminska S, Lomper K, Chudiak A, Ausili D, Uchmanowicz I. The association of the level of self-care on adherence to treatment in patients diagnosed with type 2 diabetes. Acta Diabetol. 2021;58:437-445. https://doi.org/10.1007/s00592-020-01628-z
43. [42] Bukhsh A, Goh BH, Zimbudzi E, Lo C, Zoungas S, Chan KG, Khan TM. Type 2 Diabetes Patients' Perspectives, Experiences, and Barriers Toward Diabetes-Related Self-Care: A Qualitative Study From Pakistan. Front Endocrinol (Lausanne). 2020;11:534873. https://doi.org/10.3389/fendo.2020.534873
44. [43] Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299-1307. https://doi.org/10.2147/PPA.S106821
45. [44] Roborel de Climens A, Pain E, Boss A, Shaunik A. Understanding Reasons for treatment discontinuation, attitudes and education needs among people who discontinue Type 2 Diabetes treatment: Results from an online patient survey in the USA and UK. Diabetes Ther. 2020;11:1873-1881. https://doi.org/10.1007/s13300-020-00843-9
46. [45] Kassavou A, Sutton S. Reasons for non-adherence to cardiometabolic medications, and acceptability of an interactive voice response intervention in patients with hypertension and type 2 diabetes in primary care: a qualitative study. BMJ Open. 2017;7(8):e015597.https://doi.org/10.1136/bmjopen-2018-024121
47. [46] Walz L, Pettersson B, Rosenqvist U, Deleskog A, Journath G, Wandell P. Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes. Patient Prefer Adherence. 2014;8:593-601. https://doi.org/10.2147/PPA.S58781
48. [47] Lopez JM, Annunziata K, Bailey RA, Rupnow MF, Morisky DE. Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence. Patient Prefer Adherence. 2014;8:683-692. http://dx.doi.org/10.2147/PPA.S58813
49. [48] de Vries ST, Keers JC, Visser R, de Zeeuw D, Haaijer-Ruskamp FM, Voorham J, Denig P. Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes. J Psychosom Res. 2014;76:134-138. http://dx.doi.org/10.1016/j.jpsychores.2013.11.003
50. [49] Zor M, Bayer N, Gölbaşi Z. Analysis of the relationship between the use of traditional and complementary medical practices and health literacy levels in individuals with type II diabetes mellitus. J Res Pharm. 2021;25(5):756-764. https://doi.org/10.29228/jrp.67
51. [50] Aljofan M, Oshibayeva A, Moldaliyev I, Saruarov Y, Maulenkul T, Gaipov A. The rate of medication nonadherence and influencing factors: A systematic Review. e-J Gen Med. 2023;20:1-11. https://doi.org/10.29333/ejgm/12946
52. [51] Decroli E, Kam A, Dillasamola D. The Percentage of Depressive Symptoms in Patients with Type 2 Diabetes Mellitus in M Djamil General Hospital Padang, Indonesia. J Res Pharm. 2019;23:292-297. https://doi.org/10.12991/jrp.2019.136
53. [52] Mansoor SM, Aslani P, Krass I. Pharmacists' attitudes and perceived barriers to provision of adherence support in Australia. Int J Clin Pharm. 2014;36:136-144. https://doi.org/10.1007/s11096-013-9840-6
54. [53] Deters MA, Laven A, Castejon A, Doucette WR, Ev LS, Krass I, Mehuys E, Obarcanin E, Schwender H, Laeer S. Effective interventions for diabetes patients by community pharmacists: A Meta-analysis of pharmaceutical care components. Ann Pharmacother. 2018;52:198-211. https://doi.org/10.1177/1060028017733272
55. [54] Jeong S, Lee M, Ji E. Effect of pharmaceutical care interventions on glycemic control in patients with diabetes: a systematic review and meta-analysis. Ther Clin Risk Manag. 2018;14:1813-1829. https://doi.org/10.2147/TCRM.S169748
56. [55] Marjadi B, Alfian R, Susanto Y, Tjandra L, Pratama ANW, Schneider C. Pharmacists' continuing professional development for non-communicable diseases management: A consensus study. Res Social Adm Pharm. 2022;18:3964-3973. https://doi.org/10.1016/j.sapharm.2022.07.002
57. [56] Al Assaf S, Zelko R, Hanko B. The Effect of Interventions Led by Community Pharmacists in Primary Care for Adults with Type 2 Diabetes Mellitus on Therapeutic Adherence and HbA1c Levels: A Systematic Review. Int J Environ Res Public Health. 2022;19(10):6188. https://doi.org/10.3390/ijerph19106188
58. [57] Alsairafi Z, Waheedi M, Alsaleh F. The perspectives of patients and physicians on the role of pharmacists in improving medication adherence in type 2 diabetes: a qualitative study. Patient Prefer Adherence. 2019;13:1527-1543. http://doi.org/10.2147/PPA.S218068
59. [58] Aditama L, Athiyah U, Utami W, Rahem A. Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya. J Basic Clin Physiol Pharmacol. 2020;30(6):/j/jbcpp.2019.30.issue-6/jbcpp-2019-0257/jbcpp-2019-0257.xml. https://doi.org/10.1515/jbcpp-2019-0257
60. [59] Iftinan GN, Elamin KM, Rahayu SA, Lestari K, Wathoni N. Application, benefits, and limitations of telepharmacy for patients with diabetes in the outpatient setting. J Multidiscip Healthc. 2023;16:451-459. https://doi.org/10.2147/JMDH.S400734
61. [60] Rabbani SA, Sharma S, Mahtab A, Pottoo FH, Sridhar SB. A systematic scoping review of implementation of telepharmacy during COVID-19. J Appl Pharm Sci. 2022;13:30-44. https://doi.org/10.7324/japs.2023.113646
62. [61] Alfian R, Athiyah U, Nita Y. Social media health interventions to improve diabetes mellitus patient outcome: a systematic review. J Basic Clin Physiol Pharmacol. 2021;32:297-304. https://doi.org/10.1515/jbcpp-2020-0501
63. [62] Gabarron E, Bradway M, Fernandez-Luque L, Chomutare T, Hansen AH, Wynn R, Arsaand E. Social media for health promotion in diabetes: study protocol for a participatory public health intervention design. BMC Health Serv Res. 2018;18:414-419. https://doi.org/10.1186/s12913-018-3178-7
64. [63] Onwuchuluba EE, Oyetunde OO, Soremekun RO. Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives. J Patient Exp. 2021;8:23743735211034338. https://doi.org/10.1177/23743735211034338
65. [64] Xie Z, Liu K, Or C, Chen J, Yan M, Wang H. An examination of the socio-demographic correlates of patient adherence to self-management behaviors and the mediating roles of health attitudes and self-efficacy among patients with coexisting type 2 diabetes and hypertension. BMC Public Health. 2020;20:1227-1240. https://doi.org/10.1186/s12889-020-09274-4
66. [65] Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, Rosas SE, Del Prato S, Mathieu C, Mingrone G, Rossing P, Tankova T, Tsapas A, Buse JB. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Associat